Trending News
News
News
Experimental Ebola Vaccine Safe, Prompts Immune Response
Results from US government-sponsored phase 1 trial of VSV vaccine reported.
News
$2.1 Million Grant Targets Antibiotic Resistance
Grant to develop small-molecules that counter antibiotic resistance in Gram-negative bacteria.
News
IUPUI Chemist Earns Grant to Improve Drug Screening in Forensics
$273,826 award to improve the speed and accuracy of mass spectrometry for detecting drugs and poisons.
News
Broad Institute of MIT and Harvard and Bayer Healthcare Expand their Partnership
Collaboration to develop therapies for cardiovascular disease.
News
Saccharin Shows Promise as Cancer Inhibitor
Researchers have found that the artificial sweetener can inhibit cancer cell growth.
News
BioTek Nominated for Department of Defense’s Top Employer Award
BioTek Instruments been nominated for the 2015 Secretary of Defense Employer Support Freedom Award by the Employer Support of the Guard and Reserve (ESGR), a Department of Defense (DoD) office.
News
BioLineRx Reports Year End 2014 Financial Results
Top-line results from Phase 2a clinical study of BL-8040 expected in the second half of 2015.
News
Luminex Begins Clinical Trials for ARIES® System and ARIES® HSV 1&2 Assay
Company plans to seek both FDA clearance and CE IVD marking this year.
News
Vanderbilt and Pittsburgh to Lead New Center to Identify Toxic Chemicals
VPROMPT will receive $6 million to develop toxicity test procedures based on three-dimensional human cell cultures.
News
apceth Initiates Phase II Clinical Trial for Pioneering Engineered Cell Therapy
Successfully completed Phase I clinical study and regulatory approval enable world’s first genetically-engineered cell therapy to enter Phase II.
Advertisement